CellCept (mycophenolate mofetil) is a prescription drug used to prevent organ rejection following certain organ transplants. The drug comes in oral forms and as a liquid solution for injection. It’s ...
CellCept can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer than that ...
19 May 2004, Basel, Switzerland – New data presented this week in over 70 abstracts at the American Transplant Congress in Boston, USA strengthen even further the body of evidence that CellCept® ...
Data presented today at the International Society for Heart and Lung Transplantation (ISHLT) annual meeting strengthens the body of evidence that CellCept (mycophenolate mofetil, MMF) has unique ...
TORONTO, June 4 /PRNewswire/ -- The 12-month results from a multicenter trial monitoring CellCept(R) (mycophenolate mofetil) in combination with calcineurin inhibitors (CNIs) in renal transplantation ...
Credit: Getty Images. The expanded approval was based on pediatric extrapolation of efficacy from adequate and well-controlled studies and pharmacokinetic data in adult heart transplant and liver ...
Mycophenolate mofetil 200mg/mL; pwd for oral susp after reconstitution; mixed fruit flavor; contains phenylalanine. Store dry powder at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) ...
June 9, 2006 — The U.S. Food and Drug Administration (FDA) has approved orphan drug status for mycophenolate mofetil in the treatment of pemphigus vulgaris; second-generation antisense drug for the ...
The FDA is warning doctors and patients that CellCept, a drug for organ transplant patients, can cause miscarriages and birth defects. Made by Roche, CellCept will get a "black box" warning that it's ...
Shares of Aspreva Pharmaceuticals Corp. sank to a new 52-week low on Wednesday after the company disclosed that the induction portion of a Phase III clinical trial of CellCept (oral mycophenolate ...
CellCept (mycophenolate mofetil) is a brand-name drug that’s prescribed to help prevent organ rejection after a transplant in adults and some children. CellCept comes in several forms. The dosage can ...
CellCept (mycophenolate mofetil) is a prescription drug that’s used to help prevent organ rejection after an organ transplant. The most common side effects reported with CellCept include diarrhea and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results